CATALOGO DEI PRODOTTI DELLA RICERCA

GAJOFATTO, Alberto
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.714
EU - Europa 8.041
AS - Asia 5.358
SA - Sud America 668
AF - Africa 236
OC - Oceania 34
Continente sconosciuto - Info sul continente non disponibili 10
Totale 23.061
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.544
RU - Federazione Russa 2.820
SG - Singapore 1.922
CN - Cina 1.732
IT - Italia 1.619
GB - Regno Unito 1.277
BR - Brasile 526
SE - Svezia 448
VN - Vietnam 436
FR - Francia 421
HK - Hong Kong 404
DE - Germania 349
IE - Irlanda 305
FI - Finlandia 296
KR - Corea 182
IN - India 135
BD - Bangladesh 112
NL - Olanda 102
CA - Canada 100
EG - Egitto 75
UA - Ucraina 75
TR - Turchia 71
JP - Giappone 58
ID - Indonesia 49
ES - Italia 48
BE - Belgio 47
AR - Argentina 46
PL - Polonia 44
PK - Pakistan 43
ZA - Sudafrica 40
AT - Austria 38
MX - Messico 37
CH - Svizzera 35
IR - Iran 34
AU - Australia 31
NG - Nigeria 31
IQ - Iraq 30
SA - Arabia Saudita 27
CL - Cile 23
EC - Ecuador 22
CZ - Repubblica Ceca 19
MA - Marocco 16
CO - Colombia 15
JO - Giordania 15
UZ - Uzbekistan 15
BJ - Benin 13
VE - Venezuela 13
GR - Grecia 12
TG - Togo 12
IL - Israele 11
MK - Macedonia 11
PY - Paraguay 11
NO - Norvegia 9
OM - Oman 9
PH - Filippine 9
AE - Emirati Arabi Uniti 8
DK - Danimarca 8
LV - Lettonia 8
MY - Malesia 8
RO - Romania 8
TN - Tunisia 8
AZ - Azerbaigian 7
CR - Costa Rica 7
EU - Europa 7
HU - Ungheria 7
LT - Lituania 7
DO - Repubblica Dominicana 6
JM - Giamaica 6
KE - Kenya 6
PT - Portogallo 6
DZ - Algeria 5
NP - Nepal 5
PE - Perù 5
SD - Sudan 5
CI - Costa d'Avorio 4
PA - Panama 4
UY - Uruguay 4
AL - Albania 3
AM - Armenia 3
BO - Bolivia 3
CY - Cipro 3
ET - Etiopia 3
GE - Georgia 3
KG - Kirghizistan 3
LK - Sri Lanka 3
ML - Mali 3
NZ - Nuova Zelanda 3
SN - Senegal 3
TH - Thailandia 3
TW - Taiwan 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AO - Angola 2
BY - Bielorussia 2
CG - Congo 2
HN - Honduras 2
HR - Croazia 2
KH - Cambogia 2
KZ - Kazakistan 2
LA - Repubblica Popolare Democratica del Laos 2
LB - Libano 2
Totale 23.022
Salva come PNG Salva come JPEG
Città #
Ashburn 1.154
Dallas 1.065
Moscow 994
Southend 987
Singapore 971
Chandler 786
San Jose 739
Hong Kong 391
Woodbridge 382
Verona 375
Ann Arbor 374
Jacksonville 331
Beijing 321
Dublin 306
New York 241
The Dalles 234
Council Bluffs 194
Houston 164
Los Angeles 156
Wilmington 126
Lawrence 122
Princeton 122
Ho Chi Minh City 120
Helsinki 114
Jinan 110
Milan 109
Nanjing 103
Hebei 88
Shenyang 88
Hanoi 84
Buffalo 79
Munich 77
Boardman 73
Santa Clara 73
Redondo Beach 62
Columbus 61
São Paulo 59
Washington 58
Rome 55
Orem 54
Tianjin 52
Zhengzhou 47
Tokyo 46
Montreal 45
Changsha 44
Lancaster 44
Brussels 43
Dong Ket 43
London 42
Redwood City 42
Hangzhou 40
Ningbo 40
Turku 40
Cairo 38
Chennai 38
Warsaw 38
Haikou 37
Nanchang 37
Amsterdam 35
Jakarta 35
Redmond 35
Guangzhou 34
Seattle 34
Bologna 32
Johannesburg 31
Taiyuan 30
Atlanta 28
Istanbul 28
Sindelfingen 28
Taizhou 28
Seoul 27
Naples 26
Abuja 24
Denver 24
Phoenix 24
Stockholm 23
Boston 22
Brooklyn 22
Frankfurt am Main 22
Chicago 21
Fuzhou 21
Catania 20
Da Nang 20
Dearborn 20
Falls Church 20
Paris 20
Tehran 20
Jiaxing 19
Shanghai 19
Toronto 19
Norwalk 18
Nuremberg 18
Padova 18
Poplar 18
Vienna 18
Lappeenranta 17
Mexico City 17
Haiphong 16
Manchester 16
Amman 15
Totale 13.740
Salva come PNG Salva come JPEG
Nome #
Tolebrutinib. Bruton tyrosine kinase (BTK) inhibitor Treatment of multiple sclerosis 637
Psicologia positiva e disabilità: affrontare le sfide del futuro nell'adulto con disabilità acquisita, cronica e progressiva 449
Analisi delle alterazioni funzionali dell’arto superiore e dell’attività muscolare mediante emgs in pazienti con sclerosi multipla: uno studio “cross-sectional” 345
The effectiveness of combining a home-based Digital motor Telerehabilitation program with conventional therapy in progressive multiple sclerosis: A study protocol for a multicenter, randomized controlled trial 326
Biopsychosocial model of resilience in young adults with multiple sclerosis (BPS-ARMS): an observational study protocol exploring psychological reactions early after diagnosis 304
A bio-psycho-social co-created intervention for young adults with multiple sclerosis (ESPRIMO): rationale and study protocol for a feasibility study 279
Gestione degli eventi avversi dei farmaci modificanti il decorso della malattia nella sclerosi multipla 263
Clinical spectrum and IgG subclass analysis of anti-myelin oligodendrocyte glycoprotein antibody-associated syndromes: a multicenter study 261
A randomized controlled trial of IV immunoglobulin in patients with postpolio syndrome. 259
Can the degree of meningeal inflammation and cortical pathology be used to stratify early progressive MS patients? 238
Two sisters with Leukoencephalopathy, hearing loss and retinopathy: a familial case of Susac's Syndrome? 234
Neurofilament light chain serum levels reflect disease severity in MOG-Ab associated disorders 232
Antibody response against HERV-W env surface peptides differentiates multiple sclerosis and neuromyelitis optica spectrum disorder 227
A Case-control study of myelin oligodendrocyte glycoprotein and CD45 polymorphisms in multiple sclerosis in Verona, Italy 226
QTc interval in patients with multiple sclerosis: an inference from the insula of Reil? 222
An exploratory panel of cerebrospinal fluid biomarkers compared to standard diagnostic evaluation in initial demyelinating events suggestive of multiple sclerosis 221
Clinical and biomarker assessment of demyelinating events suggesting multiple sclerosis. 221
EFFETTI DI UN TRAINING DI INTEGRAZIONE SENSORI – MOTORIA SUI DISTURBI DELL’EQUILIBRIO IN PAZIENTI CON SCLEROSI MULTIPLA: UNO STUDIO RANDOMIZZATO CONTROLLATO 221
Insights for fostering resilience in young adults with multiple sclerosis in the aftermath of the COVID-19 emergency: an Italian survey 220
Un caso di sclerosi multipla con esordio "tumor-like" e decorso benigno 219
Prevalence of multiple sclerosis in Verona, Italy: an epidemiologic and genetic study 217
Levofloxacin-induced hemichorea-hemiballism in a patient with previous thalamic infarction 216
A multicenter study on the diagnostic significance of a single cerebrospinal fluid IgG band 214
“If You Can’t Control the Wind, Adjust Your Sail”: Tips for Post-Pandemic Benefit Finding from Young Adults Living with Multiple Sclerosis. A Qualitative Study 214
Are cerebrospinal fluid biomarkers useful in predicting the prognosis of multiple sclerosis patients? 211
A case of acute fulminant multiple sclerosis treated with alemtuzumab 211
An active case of radiologically isolated syndrome: from MRI detection to multiple sclerosis 210
GLI EFFETTI DI DUE DIVERSI TIPI DI TRATTAMENTO MOTORIO SULLE FUNZIONI COGNITIVE IN PAZIENTI CON SCLEROSI MULTIPLA 210
Brentuximab vedotin: axonal microtubule's Apollyon 209
Relevance of antibodies to myelin oligodendrocyte glycoprotein in CSF of seronegative cases 209
Cognitive onset in multiple sclerosis 208
A panel of exploratory CSF biomarkers in patients with an initial demyelinating event of the CNS: does it add relevant information to usual work-up? 208
2017 McDonald criteria for multiple sclerosis: Earlier diagnosis with reduced specificity? 207
Risk factors for post-polio syndrome among an Italian population: a case-control study. 205
Assessment of outcome predictors in first-episode acute myelitis: a retrospective study of 53 cases. 204
A case of multiple sclerosis and necrotizing autoimmune myopathy with anti-SRP antibodies 204
A case of multifocal CIS with unusual MRI features suggestive of Balo's concentric sclerosis 203
Intravenous immunoglobulin for post-polio syndrome: a randomized double-blind, placebo-controlled study 200
e-ESPRIMO: An e-health biopsychosocial intervention for young adults with Multiple sclerosis and medium/high disability. Co-creation phase 194
High-intensity robot-assisted hand training in individuals with multiple sclerosis: a randomized, controlled, single-blinded trial 194
Antibody response against HERV-W in patients with MOG-IgG associated disorders, multiple sclerosis and NMOSD 190
Correlation between cerebrospinal fluid markers of neurodegeneration and MRI measures of gray matter pathology in multiple sclerosis 189
Late-onset multiple sclerosis presenting with cognitive dysfunction and severe cortical/infratentorial atrophy. 186
Amyloid myopathy: an intriguing diagnosis 186
Benign multiple sclerosis: physical and cognitive impairment follow distinct evolutions 185
Benign course of tumour-like multiple sclerosis. Report of five cases and literature review. 184
Characterization of Upper Limb Impairments at Body Function, Activity, and Participation in Persons With Multiple Sclerosis by Behavioral and EMG Assessment: A Cross-Sectional Study 184
Are natalizumab and fingolimod analogous second-line options for the treatment of relapsing-remitting multiple sclerosis? A clinical practice observational study. 181
Epilepsy in multiple sclerosis: The role of temporal lobe damage 181
Prevalence of multiple sclerosis in Verona, Italy: an epidemiological and genetic study. 180
A multicentRE observational analysiS of PErsistenCe to Treatment in the new multiple sclerosis era: the RESPECT study 180
Acute cardiovascular dysfunction in multiple sclerosis: report of two cases and literature review 177
HPV-related papillary squamous cell carcinoma of the tonsil during treatment with fingolimod 176
EFFECTIVENESS OF A SENSORIMOTOR INTEGRATION TRAINING ON BALANCE DISORDERS IN PATIENTS WITH MULTIPLE SCLEROSIS: A RANDOMIZED CONTROLLED TRIAL 175
Response to Nagai et al. 175
Physical disability and cognitive impairment evolution in benign multiple sclerosis: a five years prospective study 171
Effects of high-intensity robot-assisted training in hand function recovery and adl independence in individuals with multiple sclerosis: A randomized controlled single-blinded trial 171
Regional distribution and evolution of grey matter changes in different MS phenotypes: a 5-year longitudinal study 170
Increase of CSF inflammatory profile in a case of highly active multiple sclerosis 170
Increased cortical lesion load and intrathecal inflammation is associated with oligoclonal bands in multiple sclerosis patients: a combined CSF and MRI study 166
Serum and CSF neurofilament light chain levels in antibody-mediated encephalitis 166
Clinical efficacy, safety, and tolerability of fingolimod for the treatment of relapsing-remitting multiple sclerosis 163
Up-regulated serum miR-128-3p in progressive and relapse-free multiple sclerosis patients 162
Dimethyl fumarate vs Teriflunomide: an Italian time-to-event data analysis 161
Promoting participatory research in chronicity: The ESPRIMO biopsychosocial intervention for young adults with multiple sclerosis 160
Evaluating upper upper limb dysfunctions in patients with multiple sclerosis: an electromyography cross sectional study 160
Effects of high-intensity robot-assisted hand training on upper limb recovery and muscle activity in individuals with multiple sclerosis: a randomized, controlled, single-blinded trial 159
Mycobacterium avium subspecies paratuberculosis and myelin basic protein specific epitopes are highly recognized by sera from patients with Neuromyelitis optica spectrum disorder 157
Cerebrospinal fluid markers in sporadic Creutzfeldt-Jakob disease. 156
Neurological complications of HIV infection in pre-HAART and HAART era: a retrospective study 155
The diagnosis of multiple sclerosis: pinpointing the concept of "no better explanation" 154
Long-term clinical, cognitive and MRI characteristics of patients with untreated benign multiple sclerosis: a natural history study 153
Inflammatory intrathecal profiles and cortical damage in multiple sclerosis 149
"Better explanations" in multiple sclerosis diagnostic workup: A 3-year longitudinal study 149
Diagnostic features of initial demyelinating events associated with serum MOG-IgG 149
Sensory integration balance training in patients with multiple sclerosis: A randomized, controlled trial 148
Two sisters with leukoencephalopathy, hearing loss and retinopathy: a familial case of Susac's syndrome? 148
Regional distribution and evolution of gray matter damage in different populations of multiple sclerosis patients 147
Sativex in resistant multiple sclerosis spasticity: Discontinuation study in a large population of Italian patients (SA.FE. study) 145
A multicenter survey on access to care in Multiple Sclerosis-related trigeminal neuralgia 145
Increased cerebrospinal fluid cystatin C may predict disability after acute myelitis 144
Changing therapeutic strategies and persistence to disease-modifying treatments in a population of multiple sclerosis patients from Veneto region, Italy 143
Resting-state functional connectivity in multiple sclerosis patients receiving nabiximols for spasticity 141
Prognostic value of multimodal evoked potentials in multiple sclerosis: the EP score. 141
Clinical and demographic predictors of response to first-line therapies in relapsing-remitting multiple sclerosis 141
Increased cortical lesion load and CSF cytokines in oligoclonal band positive MS patients 141
HCV-related nervous system disorders. 138
Long survival and clinical stability in Marburg's variant multiple sclerosis. 137
Physicochemical properties of Aβ peptides in cerebrospinal fluid of Alzheimer’s disease patients 137
Refractory trigeminal neuralgia responsive to nabiximols in a patient with multiple sclerosis 136
Hepatitis C virus-associated neurocognitive and neuropsychiatric disorders: Advances in 2015 134
Prognostic factors of acute partial transverse myelitis. 129
Risk of disease relapse following COVID-19 vaccination in patients with AQP4-IgG-positive NMOSD and MOGAD 129
Ofatumumab for relapsing forms of multiple sclerosis 128
Do patients' and referral centers' characteristics influence multiple sclerosis phenotypes? Results from the Italian multiple sclerosis and related disorders register 127
Switching multiple sclerosis patients with breakthrough disease to second-line therapy. 127
Early predictors of recovery, symptom recurrence, conversion to multiple sclerosis and long-term disability after acute myelitis 127
Clinical, MRI, and CSF markers of disability progression in multiple sclerosis 126
Brain Volume Measures in Adults with MOG-Antibody-Associated Disease: A Longitudinal Multicenter Study 125
Long lesions on initial spinal cord MRI predict a final diagnosis of acute disseminated encephalomyelitis versus multiple sclerosis in children 125
Totale 19.091
Salva come PNG Salva come JPEG
Categoria #
all - tutte 74.563
article - articoli 70.070
book - libri 0
conference - conferenze 2.616
curatela - curatele 0
other - altro 553
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.324
Totale 149.126
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202196 0 0 0 0 0 0 0 0 0 0 0 96
2021/20221.177 98 418 31 123 27 23 11 74 36 32 74 230
2022/20232.274 153 291 212 372 175 483 30 142 246 30 88 52
2023/20241.867 65 114 181 157 241 402 92 154 20 107 178 156
2024/20253.312 169 200 201 486 174 148 188 178 478 246 274 570
2025/202610.218 680 484 1.092 1.534 2.521 610 863 490 850 580 247 267
Totale 23.291